Orange Book product · Generic (ANDA)
ENOXAPARIN SODIUM
ENOXAPARIN SODIUM
At a glance
Jun 14, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 14, 2022
4 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
ENOXAPARIN SODIUM
Strength
300MG/3ML (100MG/ML)
Dosage form
INJECTABLE
Route
INTRAVENOUS, SUBCUTANEOUS
TE code
AB
Application
ANDA 214856
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ENOXAPARIN SODIUM
- 2003LOVENOXBrand (NDA)
NDA 020164 · SANOFI AVENTIS US
- 2026ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 218775 · HEBEI CHANGSHAN
- 2023ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 214646 · BE PHARMS
- 2023ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 205660 · SHENZHEN TECHDOW
- 2019ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 206834 · EMERGE BIOSCIENCE
- 2019ENOXAPARIN SODIUMGeneric (ANDA)
ANDA 208600 · AMPHASTAR PHARMS INC
- 2018ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 078990 · GLAND
- 2014ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 076726 · ZYDUS PHARMS
- 2011ENOXAPARIN SODIUMGeneric (ANDA)
ANDA 078660 · SANDOZ INC
- 2011ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 076684 · AMPHASTAR PHARM
- 2010ENOXAPARIN SODIUM (PRESERVATIVE FREE)Generic (ANDA)
ANDA 077857 · SANDOZ
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
